Mar 23, 2020, 01:00 by admin admin

ASAM and the AMA are recommending that states with declared states of emergency request blanket exceptions from the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) that will help patients in an Opioid Treatment Program (OTP) during the COVID-19 pandemic.

Mar 19, 2020, 01:00 by admin admin

LSAM submitted a letter in support of SB213, which would which would require that medical necessity determinations related to substance use disorder (SUD) be made in accordance with the ASAM Criteria by certain insurance policies.

Mar 13, 2020, 01:00 by admin admin

ASAM sent a letter urging key legislators to appropriate funding for programs to bolster the addiction treatment workforce.

Mar 10, 2020, 01:00 by admin admin

ASAM Board Member Dr. Anika Alvanzo attended a panel discussion on the opioid epidemic hosted by The Hill. She used the discussion to highlight various pieces of legislation currently under consideration by Congress that would help turn the corner on the opioid overdose epidemic.

Mar 5, 2020, 01:00 by admin admin

Various stakeholders, including Kim Brandt, the Principal Deputy Administrator for Policy & Operations at CMS, and Dr. Shawn Ryan, the chair of ASAM's Legislative Advocacy Committee, testified before the Subcommittee on Health of the Committee on Energy and Commerce.

Feb 13, 2020, 01:00 by admin admin

ASAM's Advocacy Roadmap outlines specific policies for strengthening the addiction treatment workforce, standardizing the delivery of individualized addiction treatment, and ensuring equitable access and coverage for comprehensive, high-quality addiction care.

Feb 3, 2020, 01:00 by admin admin

The Further Consolidated Appropriations Act, 2020 (H.R. 1865) Expands Funding for an Addiction Treatment Workforce That Is Currently Insufficient Given Addiction Epidemic in US.

Feb 3, 2020, 01:00 by admin admin

ASAM provided its comments on proposed changes to regulations under the Federal anti-kickback statute (AKS).

Dec 11, 2019, 01:00 by admin admin

ASAM submitted a letter of support for the proposal by the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention to add ICD-10-CM codes for synthetic cannabinoid use and poisoning.

Dec 6, 2019, 01:00 by admin admin

ASAM attended the Graduate Medical Education Advocacy Coalition's Day of Action to advocate for passage of the Opioid Workforce Act and expanded training opportunities for the addiction treatment workforce.

Nov 20, 2019, 01:00 by admin admin

Resolution Recognizes Addiction as a Complex Medical Disease, Urges Support for Evidence-Based Treatment, and Supports Efforts to Prevent and Destigmatize Substance Use Disorder and Addiction

Oct 21, 2019, 01:00 by admin admin

ASAM sent a letter to Representatives Frank Pallone and Donna Shalala expressing strong support for the Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339).

Oct 18, 2019, 01:00 by admin admin

ASAM applauds a provision of the Reversing the Youth Tobacco Epidemic Act that would ban menthol cigarettes, observing that menthol cigarettes are uniquely attractive to youth.

Oct 17, 2019, 01:00 by admin admin

ASAM mourns the loss of the longtime Maryland Congressman who was a tireless advocate for the people he served and a true champion for expanding access to addiction treatment and recovery in the US.

Oct 3, 2019, 01:00 by admin admin

The American Society of Addiction Medicine (ASAM) and 28 of its chapters –– sent a letter to Senate Majority Leader Mitch McConnell and Senator Minority Leader Chuck Schumer urging the US Senate to pass swiftly comprehensive legislation to address the opioid overdose epidemic.

Sep 27, 2019, 01:00 by admin admin

ASAM sent a letter urging members of Congress to support the Stopping Appealing Flavors in E-Cigarettes for Kids Act (SAFE Kids Act), which would place significant restrictions upon flavored tobacco products.

Sep 27, 2019, 01:00 by admin admin

ASAM submitted comments on a Notice of Proposed Rulemaking (NPRM) regarding Confidentiality of Substance Use Disorder Patient Records which would expand the ability of law enforcement to access records protected by 42 CFR Part 2.

Sep 27, 2019, 01:00 by admin admin

ASAM submitted its comments on SAMHSA's NPRM Regarding Confidentiality of Substance Use Disorder Patient Records, which would make significant regulatory changes to 42 CFR Part 2

Sep 27, 2019, 01:00 by admin admin

ASAM submitted its comments on the 2020 Medicare Physician Fee Schedule proposed rule, which focus on the two newly proposed payment bundles for the treatment of opioid use disorder, and a provision of the proposed rule that would permit CMS to revoke or deny Medicare enrollment for physicians and eligible professionals under certain circumstances.

Sep 27, 2019, 01:00 by admin admin

ASAM joined 47 other organizations in urging Congress to oppose the Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019, which would exempt certain tobacco products from FDA regulation